Saturday, April 17, 2021

Repligen Company (RGEN) named price of Common Stock Shares

Repligen Company (NASDAQ: RGEN) today announced the pricing of an underwritten public offering at a public offering price of $181 per share for 1.5 million shares of its common stock.

Repligen Company has also given the underwriters a 30-day chance to buy up to 225,000 additional common stock securities, fewer discounts, and commissions at the public bidding offer. Repligen estimates the revenue from the offering to be roughly around $271.5 million before deducting the underwriting discounts and fees and other offering costs, minus any exercise of the underwriters’ choice to buy additional stock. Subject to standard closing terms, the offering is scheduled to close on or around 10 December 2020.


A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .

Sponsored


Repligen Company plans to use the net proceeds from this sale for working capital and other general corporate needs. Net profits from this deal can also be used to support future sales or acquisitions in supplementary entities, goods, facilities, and technology. At this time, Repligen has not entered into any agreements or commitments about any acquisitions or investments.

These shares will be offered and distributed in compliance with the Securities and Exchange Commission (S.E.C.) and an immediately effective declaration of the shelf’s registration (including the base prospect), which had been previously submitted. A preliminary supplement to the prospectus related to this bid was submitted with the S.E.C. If available, copies of the final supplement to the prospectus and the accompanying prospectus relating to this offering can be obtained from J.P. Morgan Securities L.L.C.

Repligen Corporation is a global life sciences organization that produces and commercializes very advanced bioprocessing technologies and systems that improve biological drug production processes’ performance. Biopharmaceutical device manufacturers and contract production and processing companies (CDMOs) worldwide are our main clients.

Latest news

What News is Causing a decrease in Jaguar Health Inc. (JAGX) Stock Price?

Jaguar Health, Inc. (NASDAQ: JAGX), announced their at-the-market (ATM) financing program to be increased by a staggering $15.3M, which was initiated on October 5,...

Investors Relieved as Workhorse Group Inc (WKHS) Stock Price Surge

Workhorse Group Inc. (WKHS) stock prices are up an impressive 13.99% shortly after the market opened on April 16th, 2021, bringing the shares up...

Timber Pharmaceuticals, Inc (TMBR) Stock Price Fall Despite a Lack of Negative Press

April 16th, 2021 has seen Timber Pharmaceuticals, Inc. (TMBR) stock prices experience a sharp decline of more than 14%, dropping down to USD$1.5192. TMBR at...

Why Torchlight Energy Resources Inc. (TRCH) stock is decreasing today?

Torchlight Energy Resources, Inc. (NASDAQ: TRCH), a company engaged in the acquisition, exploration, of oil and gas,  announced that it is working to finish...

Related news

What News is Causing a decrease in Jaguar Health Inc. (JAGX) Stock Price?

Jaguar Health, Inc. (NASDAQ: JAGX), announced their at-the-market (ATM) financing program to be increased by a staggering $15.3M, which was initiated on October 5,...

Investors Relieved as Workhorse Group Inc (WKHS) Stock Price Surge

Workhorse Group Inc. (WKHS) stock prices are up an impressive 13.99% shortly after the market opened on April 16th, 2021, bringing the shares up...

Timber Pharmaceuticals, Inc (TMBR) Stock Price Fall Despite a Lack of Negative Press

April 16th, 2021 has seen Timber Pharmaceuticals, Inc. (TMBR) stock prices experience a sharp decline of more than 14%, dropping down to USD$1.5192. TMBR at...

Why Torchlight Energy Resources Inc. (TRCH) stock is decreasing today?

Torchlight Energy Resources, Inc. (NASDAQ: TRCH), a company engaged in the acquisition, exploration, of oil and gas,  announced that it is working to finish...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.